{{Rsnum
|rsid=13385
|Gene=HBEGF
|Chromosome=5
|position=140333293
|Orientation=minus
|GMAF=0.2158
|Gene_s=HBEGF
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 55.8 | 36.3 | 8.0
| HCB | 54.0 | 37.2 | 8.8
| JPT | 31.0 | 48.7 | 20.4
| YRI | 92.5 | 7.5 | 0.0
| ASW | 87.7 | 10.5 | 1.8
| CHB | 54.0 | 37.2 | 8.8
| CHD | 51.4 | 37.6 | 11.0
| GIH | 56.4 | 37.6 | 5.9
| LWK | 90.9 | 9.1 | 0.0
| MEX | 62.1 | 32.8 | 5.2
| MKK | 72.9 | 25.8 | 1.3
| TSI | 68.6 | 24.5 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22319602
|Title=A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy
|OA=1
}}

{{PMID Auto
|PMID=22136955
|Title=Haplotypes of heparin-binding epidermal-growth-factor-like growth factor gene are associated with pre-eclampsia.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}